263 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 6 | next »
Genei Gene descriptioni x Protein classi x Tissuei Celli Pathologyi Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
MARC2Mitochondrial amidoxime reducing component 2Predicted intracellular proteins
Predicted membrane proteins
Liver cancer: 1.40e-10
Renal cancer: 3.09e-4
Tissue enhanced
BTNL9Butyrophilin like 9Predicted membrane proteins
Nuclear membrane
Vesicles
Liver cancer: 1.55e-9
Endometrial cancer: 7.51e-4
Tissue enhanced
CLEC3BC-type lectin domain family 3 member BCancer-related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Liver cancer: 9.99e-9
Head and neck cancer: 1.53e-4
Pancreatic cancer: 5.68e-4
Tissue enhanced
RBP4Retinol binding protein 4Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Liver cancer: 1.74e-8
Endometrial cancer: 1.50e-4
Tissue enriched
LCATLecithin-cholesterol acyltransferaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
NucleoplasmLiver cancer: 4.21e-8
Renal cancer: 1.71e-4
Colorectal cancer: 8.50e-4
Expressed in all
APOC1Apolipoprotein C1Cancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Liver cancer: 1.15e-7
Tissue enriched
UPB1Beta-ureidopropionase 1Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Liver cancer: 2.30e-7
Group enriched
APOHApolipoprotein HCandidate cardiovascular disease genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatusLiver cancer: 2.39e-7
Renal cancer: 1.10e-6
Tissue enriched
HMGCS23-hydroxy-3-methylglutaryl-CoA synthase 2Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
MitochondriaLiver cancer: 2.43e-7
Renal cancer: 3.43e-5
Ovarian cancer: 2.17e-4
Tissue enhanced
ALDH2Aldehyde dehydrogenase 2 family (mitochondrial)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Liver cancer: 3.95e-7
Renal cancer: 5.24e-6
Endometrial cancer: 2.63e-4
Urothelial cancer: 7.71e-4
Expressed in all
LIMS2LIM zinc finger domain containing 2Disease related genes
Predicted intracellular proteins
Focal adhesion sitesLiver cancer: 6.53e-7
Mixed
PON1Paraoxonase 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted secreted proteins
Transporters
Liver cancer: 7.24e-7
Tissue enriched
BDH13-hydroxybutyrate dehydrogenase 1Candidate cardiovascular disease genes
Enzymes
Predicted intracellular proteins
MitochondriaRenal cancer: 7.12e-8
Liver cancer: 9.86e-7
Cervical cancer: 1.09e-4
Tissue enriched
SOCS2Suppressor of cytokine signaling 2Predicted intracellular proteins
Endoplasmic reticulumPancreatic cancer: 8.17e-7
Liver cancer: 1.09e-6
Expressed in all
DNASE1L3Deoxyribonuclease 1 like 3Disease related genes
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 1.06e-7
Liver cancer: 1.20e-6
Tissue enhanced
KNG1Kininogen 1Disease related genes
Plasma proteins
Predicted secreted proteins
Liver cancer: 1.28e-6
Group enriched
MTHFSMethenyltetrahydrofolate synthetaseEnzymes
Predicted intracellular proteins
CytosolLiver cancer: 1.29e-6
Renal cancer: 2.04e-4
Glioma: 6.94e-4
Expressed in all
CFHR4Complement factor H related 4Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Liver cancer: 1.57e-6
Tissue enriched
PDE2APhosphodiesterase 2AEnzymes
Predicted intracellular proteins
Predicted secreted proteins
CytosolLiver cancer: 1.76e-6
Tissue enhanced
SPP2Secreted phosphoprotein 2Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Liver cancer: 2.33e-6
Tissue enriched
RAMP3Receptor activity modifying protein 3FDA approved drug targets
Predicted membrane proteins
Liver cancer: 2.50e-6
Cervical cancer: 2.89e-4
Tissue enhanced
GHRGrowth hormone receptorDisease related genes
FDA approved drug targets
Predicted membrane proteins
Plasma membrane
Cytosol
Cytoplasmic bodies
Liver cancer: 2.73e-6
Group enriched
CYP2C9Cytochrome P450 family 2 subfamily C member 9Enzymes
Predicted secreted proteins
Liver cancer: 2.83e-6
Tissue enriched
RTP3Receptor transporter protein 3Predicted membrane proteins
MitochondriaLiver cancer: 3.11e-6
Tissue enriched
PPARGC1APPARG coactivator 1 alphaCancer-related genes
Predicted intracellular proteins
NucleoplasmRenal cancer: 1.49e-14
Liver cancer: 3.35e-6
Thyroid cancer: 5.80e-4
Mixed
ANXA10Annexin A10Predicted intracellular proteins
Nucleus
Nucleoli
Vesicles
Liver cancer: 3.64e-6
Tissue enriched
ITM2AIntegral membrane protein 2APredicted intracellular proteins
Predicted membrane proteins
NucleoplasmLiver cancer: 3.66e-6
Expressed in all
CHP1Calcineurin like EF-hand protein 1Plasma proteins
Predicted intracellular proteins
VesiclesRenal cancer: 2.79e-6
Liver cancer: 4.07e-6
Endometrial cancer: 9.63e-4
Expressed in all
TMEM88Transmembrane protein 88Predicted membrane proteins
Liver cancer: 4.43e-6
Colorectal cancer: 1.16e-4
Mixed
CYB5D2Cytochrome b5 domain containing 2Predicted intracellular proteins
Predicted secreted proteins
Nuclear membrane
Nucleoli
Centrosome
Renal cancer: 2.03e-10
Liver cancer: 4.98e-6
Pancreatic cancer: 7.76e-5
Endometrial cancer: 6.19e-4
Expressed in all
HAGHHydroxyacylglutathione hydrolaseEnzymes
Plasma proteins
Predicted intracellular proteins
Renal cancer: 1.81e-6
Liver cancer: 5.33e-6
Cervical cancer: 5.82e-5
Urothelial cancer: 5.19e-4
Expressed in all
SLC22A7Solute carrier family 22 member 7Predicted membrane proteins
Transporters
Liver cancer: 5.48e-6
Renal cancer: 8.98e-4
Group enriched
ENGEndoglinCancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
Plasma proteins
Predicted membrane proteins
Liver cancer: 5.62e-6
Renal cancer: 4.26e-4
Head and neck cancer: 6.61e-4
Expressed in all
ADH4Alcohol dehydrogenase 4 (class II), pi polypeptideEnzymes
Plasma proteins
Predicted intracellular proteins
Nucleus
Cytosol
Liver cancer: 7.08e-6
Tissue enriched
IGSF23Immunoglobulin superfamily member 23Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Cell Junctions
Liver cancer: 7.20e-6
Group enriched
ALDH5A1Aldehyde dehydrogenase 5 family member A1Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
MitochondriaLiver cancer: 7.61e-6
Renal cancer: 3.68e-4
Ovarian cancer: 6.20e-4
Expressed in all
TMPRSS6Transmembrane protease, serine 6Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Liver cancer: 8.16e-6
Group enriched
CYP27A1Cytochrome P450 family 27 subfamily A member 1Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
MitochondriaLiver cancer: 8.62e-6
Breast cancer: 1.05e-4
Tissue enhanced
CFHR1Complement factor H related 1Cancer-related genes
Plasma proteins
Predicted secreted proteins
VesiclesLiver cancer: 8.71e-6
Tissue enriched
SLC10A1Solute carrier family 10 member 1Predicted membrane proteins
Transporters
Liver cancer: 9.53e-6
Tissue enriched
RIDAReactive intermediate imine deaminase A homologPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Liver cancer: 9.61e-6
Group enriched
MYH11Myosin heavy chain 11Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol
Liver cancer: 1.10e-5
Tissue enhanced
DHRS1Dehydrogenase/reductase 1Predicted intracellular proteins
Nucleus
Centrosome
Cytosol
Liver cancer: 1.18e-5
Lung cancer: 6.83e-4
Expressed in all
SLC22A1Solute carrier family 22 member 1Predicted intracellular proteins
Predicted membrane proteins
Transporters
Liver cancer: 1.35e-5
Tissue enriched
ACSM2AAcyl-CoA synthetase medium-chain family member 2AEnzymes
Predicted intracellular proteins
Predicted membrane proteins
Liver cancer: 1.41e-5
Group enriched
ACAT1Acetyl-CoA acetyltransferase 1Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
MitochondriaRenal cancer: 0.00e+0
Liver cancer: 1.43e-5
Expressed in all
GPTGlutamic--pyruvic transaminaseEnzymes
Plasma proteins
Predicted intracellular proteins
Liver cancer: 1.47e-5
Renal cancer: 2.19e-4
Mixed
SORBS2Sorbin and SH3 domain containing 2Predicted intracellular proteins
NucleoplasmRenal cancer: 3.10e-6
Liver cancer: 1.47e-5
Endometrial cancer: 6.07e-5
Tissue enhanced
TTC36Tetratricopeptide repeat domain 36Predicted intracellular proteins
NucleoplasmLiver cancer: 1.81e-5
Tissue enhanced
ALAS15'-aminolevulinate synthase 1Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Mitochondria
Renal cancer: 6.06e-7
Liver cancer: 1.82e-5
Expressed in all
Page of 6 | next »